EP 1082340 A1 20010314 - PEPTIDE VACCINE FOR CANINE ALLERGY
Title (en)
PEPTIDE VACCINE FOR CANINE ALLERGY
Title (de)
PEPTID IMPFSTOFF GEGEN HUNDE- ALLERGIE
Title (fr)
VACCIN PEPTIDIQUE POUR ALLERGIE CANINE
Publication
Application
Priority
- US 0008523 W 20000330
- US 28176199 A 19990330
Abstract (en)
[origin: WO0058349A1] Disclosed is an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair, such as having the configuration: leucine-blank-blank-tyrosine-arginine, tyrosine-arginine-blank-blank-leucine, or, leucine-blank-blank-tyrosine-arginine-blank-blank-leucine, where blank is any amino acid. Other peptides of the invention include those with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine; cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine. The peptides can be linked to a carrier such as a multiply antigen protein or a plant virus particle. Isolated and purified peptides of the invention can be used to induce canine autoantibodies directed to the canine igE molecule.
IPC 1-7
IPC 8 full level
C12P 21/08 (2006.01); A61K 38/00 (2006.01); A61P 37/08 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 16/06 (2006.01); C07K 16/28 (2006.01); C07K 16/44 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61P 37/08 (2018.01 - EP); C07K 7/06 (2013.01 - EP); C07K 7/08 (2013.01 - EP); C07K 16/065 (2013.01 - EP); C07K 16/2803 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); C07K 2317/34 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0058349 A1 20001005; AU 4053600 A 20001016; CA 2329152 A1 20001005; EP 1082340 A1 20010314; JP 2002540217 A 20021126
DOCDB simple family (application)
US 0008523 W 20000330; AU 4053600 A 20000330; CA 2329152 A 20000330; EP 00919927 A 20000330; JP 2000608048 A 20000330